The European Commission has not yet renewed the order for Covid vaccines to AstraZeneca, the Anglo-Swedish company against which a lawsuit has been launched in recent weeks for breach of the contract. The European Commissioner for the Internal Market Thierry Breton said to ‘France Inter’: “We have not renewed the order after June. We will see what happens”. Read also In recent days, in the meantime, in Great Britain it was decided that an alternative to the product developed by the University of Oxford will be offered for people under 40, where available. The decision follows the recommendations of the Joint Committee on Vaccination and Immunization on the risks of thrombosis, specifying that this must not slow down the vaccination campaign. People between the ages of 30 and 39 will therefore be offered the opportunity to vaccinate with Pfizer / BioNTech or Nih / Moderna in the UK, while in Germany, AstraZeneca could be chosen by everyone without age limit. Any adult who requests it from their GP may soon have the vaccine from the Anglo-Swedish company, regardless of which priority group they belong to. The new measure was announced in recent days by the Minister of Health, Jens Spahn. The plan, which must still obtain final approval, aims to increase the number and pace of anti-Covid vaccinations.
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.